European Parliament approves European Medicines Agency accounts for 2024
10 Sep 2026Effective: 29 Apr 20268 views
Who is affected:
Pharmaceutical industry, regulatory bodies and European healthcare sector
Summary
The European Parliament approves how the European Medicines Agency managed its budget in 2024. It is a mandatory annual financial control procedure.
Detailed analysis
PRO
The European Parliament approves the budgetary management of the European Medicines Agency (EMA) for the 2024 financial year, in accordance with the discharge procedure provided for in the EU Financial Regulation. This decision implies that auditors and Parliament have considered the agency's budget execution satisfact…
PRO exclusive content
Implicaciones prácticas, plazos y recomendaciones específicas para tu sector.
OJ:L_202601631: Decisión (UE) 2026/1631 del Parlamento Europeo, de 29 de abril de 2026, sobre la aprobación de la gestión en la ejecución del presupuesto de la Agencia Europea de Medicamentos para el ejercicio 2024
The European Central Bank modifies how it internally delegates decisions on risk models used by major European banks. It affects banking supervision but does no...
Significant credit institutions directly supervised by the ECB
The European Central Bank allows its supervisory officials to directly approve restructuring plans for banking groups. It streamlines decision-making in Europea...
Significant banking groups supervised by the ECB and their supervision teams
The European Commission requires the registration of imports of steel shelving from China to be able to collect anti-dumping duties retroactively if dumping is ...
European importers of Chinese steel shelving, distributors and logistics sector
The European Commission authorizes the signing of agreements that update the monetary agreements with Andorra and San Marino, which use the euro without being E...
Financial entities, companies and citizens with economic activity in Andorra and San Marino
The European Commission approves ELOCLEAR biocide as an authorized product throughout the EU. This authorization permits its marketing and use in accordance wit...
Manufacturers, distributors and professional users of biocides in the EU
The EU administratively updates the authorization of the LANXESS CMIT/MIT biocide group. The changes are minor and do not alter the essential conditions of the ...
Manufacturers, distributors and industrial users of CMIT/MIT biocides in the EU
